Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

CEMEX downgraded by Barclays, price target set to $9

Published 09/02/2024, 15:26
© Reuters.

On Friday, Barclays adjusted its stance on shares of CEMEX (NYSE:CX), moving the rating from Overweight to Equal-weight. The firm also established a price target of $9.00 for the company's stock. This decision follows CEMEX's fourth-quarter results of 2023, which aligned with Barclays' projections but were marginally lower than the Bloomberg consensus. The company's sales and EBITDA fell approximately 1% short of expectations, although it managed to meet the anticipated EBITDA margin of 17.5%, marking a year-over-year improvement of 120 basis points.

The analyst noted that CEMEX demonstrated robust free cash flow generation and has reached a position of relatively low leverage. As a result of its financial performance, CEMEX plans to initiate a dividend payment, distributing $120 million to shareholders starting in the second quarter of 2024.

The performance metrics for the fourth quarter were critical to Barclays' assessment, with EBITDA—a measure of a company's operating profitability—being a key focus. The EBITDA margin serves as an indicator of operating efficiency, and CEMEX's ability to hit the target margin reflects a solid operational stance, despite sales and EBITDA not fully meeting expectations.

The announcement of the dividend payment is noteworthy as it represents a shift in CEMEX's capital allocation strategy, signaling confidence in its financial health and a commitment to returning value to its shareholders. The $120 million dividend payment is set to commence in the second quarter of 2024.

Barclays' updated price target of $9.00 offers a reference for investors regarding the firm's valuation of CEMEX's stock. The change in rating to Equal-weight suggests that the analyst now views the company's stock as being appropriately valued, considering the current information and financial results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.